Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Register now for USCA 2019, held September 5 to 8 in DC. Here’s a peek at the speakers and workshops.
The court case could eliminate protections for people with pre-existing conditions. Plus 20 million Americans could lose their insurance.
Jeffrey Parsons stepped down from his CUNY post after complaints of sexual misconduct and cocaine use at parties
HIV-positive people who underwent surgery to remove early lung cancer fared as well as HIV-negative people.
These are the four pillars of the pilot program.
Generalized anxiety disorder is associated with lower rates of HIV treatment, adherence to treatment and viral suppression.
Meet the real people of color behind Houston’s effort to educate about PrEP and TasP.
A new analysis of the global START trial found that health outcomes were better for those starting treatment within six months.
A look at what the law says about buying prescription drugs from Canada.
After almost a decade on antiretroviral therapy, half of study participants still had HIV in immune cells in their brain and spinal fluid.
Investigators led by Scripps Research will study vaccines that coax the immune system into creating antibodies that protect against HIV.
Electronic prompts for clinicians to recommend Truvada to people at risk for HIV could help increase PrEP’s impact.
Researchers compared outcomes between babies born to HIV-positive mothers exposed to antiretrovirals and those who were not.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.